Ultrasound in Detecting Lymph Node Metastasis in Older Patients Undergoing Breast Sonography
NCT ID: NCT01681901
Last Updated: 2017-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2006-06-07
2007-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
NCT05704283
Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer
NCT02019303
Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes
NCT04185337
Benign-Malign Differentiation of Axillary Lymph Nodes: The Role Of Superb Microvascular Imaging
NCT05927727
Combining MRI and CEUS to Diagnose Small Cervical Lymph Node Metastases in NPC Patients
NCT05389306
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To develop a reliable and consistent set of guidelines for utilizing diagnostic ultrasound to assess axillary lymph nodes for patient suspicious of breast cancer with possible nodal metastasis.
SECONDARY OBJECTIVES:
I. To explore whether the data collected can be used for pathologic validation of metastatic disease.
OUTLINE:
Patients undergo breast ultrasound.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnostic (ultrasound)
Patients undergo breast ultrasound imaging.
ultrasound imaging
Undergo ultrasound
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound imaging
Undergo ultrasound
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have had a mammogram with a Breast Imaging Reporting and Data System (BIRADS) of \>= 4
* Patients who are undiagnosed for breast cancer
Exclusion Criteria
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ohio State University Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kevin Evans
Role: PRINCIPAL_INVESTIGATOR
Ohio State University Comprehensive Cancer Center
Related Links
Access external resources that provide additional context or updates about the study.
The Jamelsine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2012-01176
Identifier Type: REGISTRY
Identifier Source: secondary_id
OSU-06010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.